Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2020-004178-23Phase 4Completed
Phase 4 trial of ropivacaine in Cardiac valve disease (VHD) and cardiac disease, sponsored by Turku University Hospital. Primary endpoint: Pain scores at rest and on movement. Started Feb 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2020-004178-23.